Fig. 2From: Design and clinical developments of aptamer-drug conjugates for targeted cancer therapy(A) ApDC constructed by Nucleotide Analogs. (B) ApDC by drug and aptamer intercalation (C) ApDC by using linker between drug and an aptamerBack to article page